Tecfidera is a medicine used to treat multiple sclerosis (MS), a disease in which inflammation damages the protective insulation around nerves (demyelination) as well as the nerves themselves. It is used in adults and children from 13 years of age with a type of MS known as relapsing-remitting MS, where the patient has flare-ups of symptoms (relapses) followed by periods of recovery (remissions). Tecfidera contains the active substance dimethyl fumarate.
Therapeutic Indication
### Therapeutic indication Tecfidera is indicated for the treatment of adult and paediatric patients aged 13 years and older with relapsing remitting multiple sclerosis (RRMS).
Therapeutic Area (MeSH)
ATC Code
L04AX07
ATC Item
dimethyl fumarate
Pharmacotherapeutic Group
Immunosuppressants
Active Substance (Summary)
N/AINN / Common Names
EMA Name
Tecfidera
Medicine Name
Tecfidera
Aliases
N/ANo risk management plan link.
